Annelise Soulier

Company: Neobe Therapeutics

Job title: Co-Founder & Chief Scientific Officer

Seminars:

Enabling Immunotherapy Responses in Solid Tumours Through Engineered Microbial Based Therapeutics 2:00 pm

Treating immunotherapy non-responders by targeting the extracellular matrix which acts as a physical barriers to effective immune infiltration to the tumour core Harnessing tumour colonising bacteria to locally disrupt the tumour extracellular matrix from within Adopting bacterial engineering approachesRead more

day: Focus Day